The United States market has shown positive momentum, rising 1.8% over the last week and 14% over the past year, with earnings projected to grow by 15% annually in the coming years. For investors seeking opportunities in smaller or newer companies, penny stocks—though an older term—still hold significant potential for value and growth. By focusing on those with strong financial foundations, these stocks can offer stability alongside promising upside potential.
Top 10 Penny Stocks In The United States
| Name | Share Price | Market Cap | Rewards & Risks |
| Waterdrop (WDH) | $1.40 | $506.33M | ✅ 4 ⚠️ 0 View Analysis > |
| WM Technology (MAPS) | $0.92 | $154.72M | ✅ 4 ⚠️ 1 View Analysis > |
| Talkspace (TALK) | $2.77 | $463.46M | ✅ 4 ⚠️ 2 View Analysis > |
| Puma Biotechnology (PBYI) | $3.58 | $177.7M | ✅ 2 ⚠️ 1 View Analysis > |
| Tuniu (TOUR) | $0.9326 | $95.78M | ✅ 3 ⚠️ 2 View Analysis > |
| Sequans Communications (SQNS) | $1.43 | $36.49M | ✅ 4 ⚠️ 4 View Analysis > |
| Cardno (COLD.F) | $0.1701 | $6.64M | ✅ 2 ⚠️ 4 View Analysis > |
| BAB (BABB) | $0.84976 | $6.17M | ✅ 2 ⚠️ 3 View Analysis > |
| TETRA Technologies (TTI) | $3.40 | $452.45M | ✅ 4 ⚠️ 2 View Analysis > |
| Tandy Leather Factory (TLF) | $3.15 | $26.81M | ✅ 2 ⚠️ 2 View Analysis > |
Click here to see the full list of 422 stocks from our US Penny Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Mercurity Fintech Holding (MFH)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Mercurity Fintech Holding Inc. is a digital fintech company offering AI-powered infrastructure, blockchain, and digital asset services in the United States with a market cap of $273.85 million.
Operations: The company's revenue primarily comes from its B2B online e-commerce platform, which generated $1.01 million.
Market Cap: $273.85M
Mercurity Fintech Holding Inc. is a digital fintech company with a market cap of US$273.85 million, currently navigating the challenges of being pre-revenue with earnings primarily from its B2B platform generating US$1.01 million annually. Despite its unprofitability and negative return on equity, the company has more cash than debt and sufficient cash runway for over three years if current trends continue. Recently included in multiple Russell Indexes, Mercurity's partnerships with Franklin Templeton and SBI Digital Markets aim to expand its blockchain-based services, potentially enhancing liquidity management and tokenized asset offerings for institutional investors.
- Click here to discover the nuances of Mercurity Fintech Holding with our detailed analytical financial health report.
- Understand Mercurity Fintech Holding's track record by examining our performance history report.
Taysha Gene Therapies (TSHA)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company that develops and commercializes adeno-associated virus-based gene therapies for treating monogenic diseases of the central nervous system, with a market cap of approximately $525.92 million.
Operations: The company's revenue segment is focused on developing AAV-based gene therapies for the treatment of rare monogenic diseases, generating $7.22 million.
Market Cap: $525.92M
Taysha Gene Therapies, Inc., with a market cap of approximately US$525.92 million, is navigating the complexities of being unprofitable in the biotech sector while focusing on developing gene therapies for rare diseases. Despite its challenges, including high volatility and negative return on equity, Taysha has a solid cash position exceeding its debt and liabilities. The company recently completed a significant follow-on equity offering raising nearly US$200 million, which bolsters its financial runway for over a year. Additionally, Taysha's inclusion in the S&P Biotechnology Select Industry Index highlights its growing recognition within the industry.
- Get an in-depth perspective on Taysha Gene Therapies' performance by reading our balance sheet health report here.
- Learn about Taysha Gene Therapies' future growth trajectory here.
Applied Energetics (AERG)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Applied Energetics, Inc. specializes in the development, manufacturing, and sale of advanced high-performance lasers and optical systems for various sectors including defense and national security, with a market cap of $493.96 million.
Operations: The company generates revenue of $2.50 million from its Aerospace & Defense segment.
Market Cap: $493.96M
Applied Energetics, Inc., with a market cap of US$493.96 million, is navigating the challenges of being unprofitable in the defense sector while focusing on high-performance laser systems. The company reported first-quarter sales of US$0.21 million and a net loss of US$3.11 million, indicating limited revenue generation. Despite having no debt and short-term assets exceeding liabilities, its cash runway is less than a year due to negative free cash flow trends. Recent leadership changes include appointing Chris Donaghey as CEO and Scott Andrews to the board, reflecting strategic governance alignment amid high share price volatility.
- Click here and access our complete financial health analysis report to understand the dynamics of Applied Energetics.
- Evaluate Applied Energetics' historical performance by accessing our past performance report.
Taking Advantage
- Embark on your investment journey to our 422 US Penny Stocks selection here.
- Curious About Other Options? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Mercurity Fintech Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com